Primary Job Title CEO Primary Organization Janpix
Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
Facebook View on Facebook LinkedIn View on LinkedIn
Roman currently serves as the CEO of Janpix, an oncology-focused start-up. He was formerly an advisor to Index Ventures and, before that, a Principal at Index, where among others he invested in and represented the firm on the boards of GlycoVaxyn (sold to GlaxoSmithKline), Versartis (Nasdaq: VSAR), and Novocure (Nasdaq: NVCR).
He started his
career at Boehringer Ingelheim Pharmaceuticals in Connecticut where he was leading development projects in oncology, inflammation and cardiovascular disease, advancing several compounds from pre-clinical to clinical stage.
Roman received a PhD from MIT as well as an MBA from NYU’s Stern School of Business. He has authored or co-authored numerous publications in prestigious journals as well as issued patents.
